SCHEMBL4195628

SCHEMBL4195628

O=S(=O)(Nc1ccccc1CNC(CC1CCCCC1)C(F)(F)F)c1cc2ccccc2s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.40
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
MCL1 Q07820 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MMP13 P45452 1/20 0.36
GHSR Q92847 1/20 0.35
F10 P00742 1/20 0.35
HDAC1 Q13547 1/20 0.34
DRD2 P14416 2/20 0.34
HTR2A P28223 2/20 0.34
HTR1A P08908 1/20 0.34
TRPA1 O75762 1/20 0.34
CA2 P00918 1/20 0.33
SYK P43405 1/20 0.32
TPSAB1 Q15661 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
OPRM1 P35372 1/20 0.31
HTR7 P34969 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4200095 0.87 CCR2 (0.41) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4197675 0.87 CCR2 (0.41) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4195304 0.87 CCR2 (0.41) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4192385 0.86 CCR2 (0.41) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4184166 0.82 CCR2 (0.43) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4192467 0.80 KDM4E (0.38) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4197433 0.80 KDM4E (0.38) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4190595 0.80 CCR2 (0.41) CCR2KDM4EPKMMCL1ALDH1A1
SCHEMBL4200050 0.79 ALDH1A1 (0.41) KDM4EPKMALDH1A1LMNA
SCHEMBL4188042 0.79 KDM4E (0.48) KDM4EPKMALDH1A1CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 CCR2 4308/4885KDM4E 3328/4885PKM 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.